Real Estate / Real Estate - DevelopmentUpdated 2026-05-10 22:07 UTC

IST/SURGY stock hub

IST/SURGY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IST/SURGYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.5B

Istanbul Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IST/SURGY

In the news

Latest news · IST/SURGY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 3.9P50 6.2P75 8.2

Trailing P/En/a

P25 5.6P50 12.6P75 19.9

ROE-4.4

P25 -1.9P50 3.5P75 10

ROIC-1.9

P25 -0.9P50 1P75 3.7

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IST/SURGY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

119

Groups with data

Currency

TRY

Showing 119 of 119 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	61
Enterprise value	TRY 13.4B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Real Estate - Development
Last refreshed	2026-05-10
Market cap	TRY 13.5B
Price	TRY 80.3
Price currency	TRY
Sector	Real Estate
Sic	6798
Symbol	ist/SURGY
Website	https://www.surtatilevlerigyo.com.tr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.93%
EV Earnings	-34.05x
P/B ratio	1.35x
PE Ratio3 Y	14.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	TRY -393.9M
Net Income Growth	126.96%
Profit Per Employee	TRY -6.5M
ROA	-1
ROCE	-1.42
ROE	-4.44
ROIC	-1.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	61.23%
EPS Growth	127

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	TRY 14.3B
Cash	TRY 36.8M
Equity	TRY 10B
Interest Coverage	-9.26
Liabilities	TRY 4.3B
Net Cash	TRY 36.8M
Net Cash By Market Cap	TRY 0.27
Net Cash Growth	-87.84%
Net Debt Equity	TRY -0
Tangible Book Value	TRY 10B
Tangible Book Value Per Share	TRY 59.56
WACC	10.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	21.73
Net Working Capital	TRY 2.6B
Quick ratio	0.29
Working Capital	TRY 2.6B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	61.18%
200-day SMA	54.57
50-day SMA	63.57
50-day SMA vs 200-day SMA	50over200
All Time High	84.45
All Time High Change	-4.91%
All Time High Date	2024-10-02
All Time Low	28.84
All Time Low Change	178.43%
All Time Low Date	2023-12-27
ATR	4.19
Beta	1.18
Beta1y	1.21
Beta2y	0.93
Ch YTD	82.5
High	80.3
High52	80.3
High52 Date	2026-05-08
High52ch	0%
Low	72.1
Low52	39.82
Low52 Date	2025-12-26
Low52ch	101.66%
Ma50ch	26.32%
Price vs 200-day SMA	47.14%
RSI	73.89
RSI Monthly	62.93
RSI Weekly	68.6
Sharpe ratio	0.96x
Sortino ratio	1.69
Tr YTD	82.5
Tr1m	50.8%
Tr1w	11.22%
Tr3m	55.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY -200.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Institutions	0.29%
Shares Out	167,499,999
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	11,572,113.55x
Bv Per Share	59.56
Ch1m	50.8
Ch1w	11.22
Ch1y	61.18
Ch3m	55.92
Ch6m	60.66
Change	10%
Change From Open	9.33
Close	73
Days Gap	0.62
Dollar Volume	210,679,989,943.5
Earnings Date	2026-05-14
EBIT	TRY -200.7M
EBITDA	TRY -198.5M
EPS	TRY -2.35
F Score	1
Fiscal Year End	December
Founded	2,022
Income Tax	TRY -74.8M
Is Primary Listing	1
Last Earnings Date	2026-03-03
Last Report Date	2025-12-31
Ma150	53.95
Ma150ch	48.83%
Ma20	69.89
Ma20ch	14.89%
Next Earnings Date	2026-05-14
Open	73.45
Position In Range	100
Ppne	58,862,217
Price Date	2026-05-08
Ptbv Ratio	1.35
Relative Volume	251.67x
Tr6m	60.66%
Volume	2,623,661,145

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IST/SURGY pay a dividend?

Capital-return profile for this ticker.

Performance

IST/SURGY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IST/SURGY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IST/SURGY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.9

Above 70: short-term overbought

Price vs 200-day MA

+47.1%

50/200-day relationship not available

Beta (5Y)

1.18

Moves roughly with the market

Sharpe ratio

0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IST/SURGY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ist/SURGY stock rating?

ist/SURGY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ist/SURGY analysis?

The full report lives at /stocks/ist/SURGY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ist/SURGY?

The latest report frames ist/SURGY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ist/SURGY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.